Canada Pension Plan Investment Board Astrazeneca PLC Transaction History

Canada Pension Plan Investment Board

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$40.12 - $45.47 $23.8 Million - $26.9 Million	-592,600 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $25.4 Million - $30.8 Million	-717,000 Reduced 54.75%	592,600 $24 Million
Q4 2018 Feb 06, 2019	SELL	$36.86 - $41.49 $29.8 Million - $33.5 Million	-807,800 Reduced 38.15%	1,309,600 $49.7 Million
Q2 2018 Aug 07, 2018	SELL	$34.55 - $37.05 $6.5 Million - $6.97 Million	-188,200 Reduced 8.16%	2,117,400 $74.3 Million
Q1 2018 May 14, 2018	BUY	$32.97 - $36.63 $33.7 Million - $37.4 Million	1,021,200 Added 79.51%	2,305,600 $80.6 Million
Q4 2017 Feb 14, 2018	BUY	$32.09 - $34.78 $36.5 Million - $39.5 Million	1,135,899 Added 764.91%	1,284,400 $44.6 Million
Q3 2017 Oct 30, 2017	BUY	$28.96 - $34.0 $4.3 Million - $5.05 Million	148,401 Added 148401.0%	148,501 $5.03 Million
Q2 2017 Jan 31, 2018	SELL	N/A	-1,771,200 Reduced 99.99%	100 $3,000
Q1 2017 Jan 31, 2018	BUY	N/A	1,771,300	1,771,300 $55.2 Million

1,334

476M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $220B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

Stay updated on Canada Pension Plan Investment Board with notifications on news.